{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17040", "batch_size": 260, "batch_pos": 161, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, superlative-negative nouns, or critical alert phrases describing the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_8824", "batch_size": 260, "batch_pos": 153, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_11616", "batch_size": 260, "batch_pos": 138, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_9256", "batch_size": 260, "batch_pos": 134, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports a business fact, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17708", "batch_size": 260, "batch_pos": 132, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_5816", "batch_size": 260, "batch_pos": 118, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment states the company can confirm they are 'in discussions', not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17232", "batch_size": 260, "batch_pos": 115, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes being in discussions ('confirm we are in discussions... on advancing our pandemic flu candidate') as a development capability without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_1736", "batch_size": 260, "batch_pos": 78, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
